dc.contributor.author | Ergenç, İlkay | |
dc.contributor.author | Yılmaz, Yusuf | |
dc.date.accessioned | 2024-10-17T08:08:05Z | |
dc.date.available | 2024-10-17T08:08:05Z | |
dc.date.issued | 2024 | en_US |
dc.identifier.citation | Ergenc, I., & Yilmaz, Y. (2024). Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring? Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18302 | en_US |
dc.identifier.issn | 0269-2813 | |
dc.identifier.uri | https://doi.org/10.1111/apt.18302 | |
dc.identifier.uri | https://hdl.handle.net/11436/9616 | |
dc.description.abstract | ..... | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Letter: Metabolic dysfunction–associated steatotic liver disease in primary biliary cholangitis—friend, foe or red herring? | en_US |
dc.type | letter | en_US |
dc.contributor.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Yılmaz, Yusuf | |
dc.identifier.doi | 10.1111/apt.18302 | en_US |
dc.relation.journal | Alimentary Pharmacology and Therapeutics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |